Net Income
Bristol-Myers Squibb Net Income increased by 67.2% to $2.20B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 80.7%, from $1.22B to $2.20B. Over 3 years (FY 2021 to FY 2024), Net Income shows a downward trend with a 8.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase signals improved profitability and potential for higher dividends or reinvestment, while a decrease may indicate rising costs or slowing sales.
Detailed definition
Net income represents the total profit of the company after all operating expenses, interest, taxes, and preferred stock...
Peer comparison
Peer companies in the consumer electronics and software sectors typically trade on multiples of this figure, though it can be impacted by one-time tax events.
cf_net_incomeHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.06B | $1.55B | $2.37B | $1.28B | $1.43B | $1.61B | $2.03B | $2.27B | $2.08B | $1.93B | $1.76B | -$11.91B | $1.68B | $1.22B | $0.00 | $2.46B | $1.31B | $2.20B |
| QoQ Change | — | +46.3% | +52.8% | -45.9% | +11.4% | +12.5% | +25.9% | +12.0% | -8.4% | -6.9% | -8.9% | -775.8% | +114.1% | -27.9% | -100.0% | — | -46.7% | +67.2% |
| YoY Change | — | — | — | — | +34.7% | +3.6% | -14.6% | +76.7% | +45.3% | +20.3% | -13.0% | -625.3% | -18.9% | -37.2% | -100.0% | +120.7% | -22.0% | +80.7% |
Net Income at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's net income?
- Bristol-Myers Squibb (BMY) reported net income of $2.20B in Q3 2025.
- How has Bristol-Myers Squibb's net income changed year-over-year?
- Bristol-Myers Squibb's net income increased by 80.7% year-over-year, from $1.22B to $2.20B.
- What is the long-term trend for Bristol-Myers Squibb's net income?
- Over 3 years (2021 to 2024), Bristol-Myers Squibb's net income has grown at a 8.7% compound annual growth rate (CAGR), from $7.01B to -$9.01B.
- What does net income mean?
- The company's total profit after all expenses and taxes have been paid.